Physical and Life Sciences Directorate
Amy Rasley has not added Biography.
If you are Amy Rasley and would like to personalize this page please email our Author Liaison for assistance.
Array2BIO: from microarray expression data to functional annotation of co-regulated genes.
BMC bioinformatics Jun, 2006 | Pubmed ID: 16780584
Generation and characterization of an attenuated mutant in a response regulator gene of Francisella tularensis live vaccine strain (LVS).
DNA and cell biology Jul, 2008 | Pubmed ID: 18613792
Francisella tularensis type A strains cause the rapid encystment of Acanthamoeba castellanii and survive in amoebal cysts for three weeks postinfection.
Applied and environmental microbiology Dec, 2009 | Pubmed ID: 19820161
Contributions of Francisella tularensis subsp. novicida chitinases and Sec secretion system to biofilm formation on chitin.
Applied and environmental microbiology Jan, 2010 | Pubmed ID: 19948864
Genetic approaches for understanding virulence in Toxoplasma gondii.
Briefings in functional genomics Nov, 2011 | Pubmed ID: 21930659
Colocalized delivery of adjuvant and antigen using nanolipoprotein particles enhances the immune response to recombinant antigens.
Journal of the American Chemical Society Feb, 2013 | Pubmed ID: 23331082
The use of nanolipoprotein particles to enhance the immunostimulatory properties of innate immune agonists against lethal influenza challenge.
Biomaterials Dec, 2013 | Pubmed ID: 24075406
Evaluation of nanolipoprotein particles (NLPs) as an in vivo delivery platform.
PloS one , 2014 | Pubmed ID: 24675794
Enhancing the efficacy of innate immune agonists: could nanolipoprotein particles hold the key?
Nanomedicine (London, England) Mar, 2014 | Pubmed ID: 24746187
Nanoparticles and antigen delivery: understanding the benefits and drawbacks of different delivery platforms.
Nanomedicine (London, England) Apr, 2014 | Pubmed ID: 24787434
Structure and function of REP34 implicates carboxypeptidase activity in Francisella tularensis host cell invasion.
The Journal of biological chemistry Oct, 2014 | Pubmed ID: 25231992
A Genome-Wide RNA Interference Screen Identifies a Role for Wnt/β-Catenin Signaling during Rift Valley Fever Virus Infection.
Journal of virology 08, 2016 | Pubmed ID: 27226375
Lipid Cross-Linking of Nanolipoprotein Particles Substantially Enhances Serum Stability and Cellular Uptake.
ACS applied materials & interfaces Aug, 2016 | Pubmed ID: 27411034
Enhancement of antigen-specific CD4 and CD8 T cell responses using a self-assembled biologic nanolipoprotein particle vaccine.
Vaccine 03, 2017 | Pubmed ID: 28214044
Cell-free production of a functional oligomeric form of a major outer-membrane protein (MOMP) for vaccine development.
The Journal of biological chemistry 09, 2017 | Pubmed ID: 28739800
Lipid-Coated Mesoporous Silica Nanoparticles for the Delivery of the ML336 Antiviral to Inhibit Encephalitic Alphavirus Infection.
Scientific reports 09, 2018 | Pubmed ID: 30228359
Coordinated Assembly of the Bacillus anthracis Coat and Exosporium during Bacterial Spore Outer Layer Formation.
mBio 11, 2018 | Pubmed ID: 30401771
Cationic HDL mimetics enhance in vivo delivery of self-replicating mRNA.
Nanomedicine : nanotechnology, biology, and medicine 02, 2020 | Pubmed ID: 31982617
Metabolic Profiling of Volatile Organic Compounds (VOCs) Emitted by the Pathogens Francisella tularensis and Bacillus anthracis in Liquid Culture.
Scientific reports 06, 2020 | Pubmed ID: 32518249
Characterization of Spore Proteins Using a Nanoscaffold Vaccine Platform.
Frontiers in immunology , 2020 | Pubmed ID: 32714323
Intranasal Nanoparticle Vaccination Elicits a Persistent, Polyfunctional CD4 T Cell Response in the Murine Lung Specific for a Highly Conserved Influenza Virus Antigen That Is Sufficient To Mediate Protection from Influenza Virus Challenge.
Journal of virology 07, 2021 | Pubmed ID: 34076479
Induction of Protection in Mice against a Respiratory Challenge by a Vaccine Formulated with the Major Outer Membrane Protein in Nanolipoprotein Particles.
Vaccines Jul, 2021 | Pubmed ID: 34358171
A Survey of Preclinical Studies Evaluating Nanoparticle-Based Vaccines Against Non-Viral Sexually Transmitted Infections.
Frontiers in pharmacology , 2021 | Pubmed ID: 34899322
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved